Real-world study of SPRINT Corroborates Published Clinical Study Results
SPR Therapeutics announced the publication of a study that evaluated the real-world impact of 60-day peripheral nerve stimulation (PNS) in the management of chronic pain. To investigate if this short-term treatment could provide long-term relief in a real-world setting, a cross-sectional survey was conducted of patients who had completed treatment at least one month prior to the survey. Some respondents had completed treatment over two years prior to the survey.
Highlights of the study, published in Pain Management, report on the responses collected from 252 survey respondents including:
More than 60 percent of patients who were responders at the time of the 60-day PNS treatment reported sustained pain relief (≥50 percent) and/or improvement in quality of life at the time of the survey, including those who were up to 30 months post-treatment.
Approximately one-third of patients using opioids or anticonvulsants (e.g., gabapentin), had stopped using them altogether or reduced use at the time of the survey.
This real-world research supports earlier published clinical trials regarding the effectiveness of a 60-day temporary PNS treatment across a wide range of painful conditions, such as chronic low back, shoulder, and knee pain targeting primarily the medial branch, axillary, and femoral nerves, respectively. The SPRINT® PNS system has been used in patients with moderate to severe pain that has proven resistant to prior conservative treatments, providing an option that ranked higher in patient preference in a recent survey when compared to ablative procedures and permanent implants.
Read more about the study here